BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21210325)

  • 1. Increased use of thrombolytic therapy and shortening of in-hospital delays following acute ischemic stroke: experience on the establishment of a primary stroke center at a community hospital.
    Sung SF; Ong CT; Wu CS; Hsu YC; Su YH
    Acta Neurol Taiwan; 2010 Dec; 19(4):246-52. PubMed ID: 21210325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
    Vaishnav AG; Pettigrew LC; Ryan S
    Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient ischemic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy?
    Uchino K; Massaro L; Hammer MD
    Cerebrovasc Dis; 2010; 29(1):57-61. PubMed ID: 19893313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous thrombolysis for ischaemic stroke: short delays and high community-based treatment rates after organisational changes in a previously inexperienced centre.
    Tveiten A; Mygland A; Ljøstad U; Thomassen L
    Emerg Med J; 2009 May; 26(5):324-6. PubMed ID: 19386862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "drip-and-ship" approach: starting IV t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center.
    Silverman IE; Beland DK; Chhabra J; McCullough LD
    Conn Med; 2005; 69(10):613-20. PubMed ID: 16381108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
    Shiotsuki H; Ogushi Y; Fushimi K; Kobayashi S;
    Tokai J Exp Clin Med; 2005 Apr; 30(1):49-62. PubMed ID: 15952299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy: the NINDS Suburban Hospital Stroke Center experience.
    Lattimore SU; Chalela J; Davis L; DeGraba T; Ezzeddine M; Haymore J; Nyquist P; Baird AE; Hallenbeck J; Warach S;
    Stroke; 2003 Jun; 34(6):e55-7. PubMed ID: 12750543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients.
    de la Ossa NP; Sánchez-Ojanguren J; Palomeras E; Millán M; Arenillas JF; Dorado L; Guerrero C; Abilleira S; Dávalos A
    Neurology; 2008 Apr; 70(15):1238-43. PubMed ID: 18322264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided.
    Boode B; Welzen V; Franke C; van Oostenbrugge R
    Cerebrovasc Dis; 2007; 23(4):294-8. PubMed ID: 17199087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic therapy for acute ischemic stroke.
    Solenski NJ
    Va Med Q; 1998; 125(2):128-30. PubMed ID: 9577716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete].
    García-García J; Gracia-Gil J; Sopelana-Garay D; Ayo-Martín O; Vadillo-Bermejo A; Touza B; Peñalver-Pardines C; Zorita MD; Segura T
    Rev Neurol; 2008 Jan 1-15; 46(1):7-12. PubMed ID: 18214820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do women benefit more from systemic thrombolysis in acute ischemic stroke? A Serbian experience with thrombolysis in ischemic stroke (SETIS) study.
    Jovanović DR; Beslać-Bumbasirević Lj; Budimkić M; Pekmezović T; Zivković M; Kostić VS;
    Clin Neurol Neurosurg; 2009 Nov; 111(9):729-32. PubMed ID: 19647928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome after thrombolysis in telemedical stroke care.
    Schwab S; Vatankhah B; Kukla C; Hauchwitz M; Bogdahn U; Fürst A; Audebert HJ; Horn M;
    Neurology; 2007 Aug; 69(9):898-903. PubMed ID: 17724293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperglycemia in thrombolysed acute ischemic stroke patients.
    Poppe AY; Hill MD
    Int J Stroke; 2011 Jun; 6(3):278; author reply 278-9. PubMed ID: 21557817
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of telemedicine to increase thrombolysis and advance care in acute ischemic stroke.
    Henninger N; Chowdhury N; Fisher M; Moonis M
    Cerebrovasc Dis; 2009; 27 Suppl 4():9-14. PubMed ID: 19546536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombolytic therapy in acute ischemic stroke: present and future].
    Mori E
    No Shinkei Geka; 2003 Mar; 31(3):249-60. PubMed ID: 12684978
    [No Abstract]   [Full Text] [Related]  

  • 20. Why are eligible thrombolysis candidates left untreated?
    Hills NK; Johnston SC
    Am J Prev Med; 2006 Dec; 31(6 Suppl 2):S210-6. PubMed ID: 17178305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.